These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11220523)

  • 21. Nonhypoglycemic effects of thiazolidinediones.
    Quesada-Gómez JM; Serrano-Alferez I
    Ann Intern Med; 2001 Dec; 135(11):1007-8. PubMed ID: 11730409
    [No Abstract]   [Full Text] [Related]  

  • 22. [New oral hypoglycemic agents].
    van Grootheest AC; Diemont WL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1911-2. PubMed ID: 11605321
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety profile of pioglitazone.
    Hanefeld M; Belcher G
    Int J Clin Pract Suppl; 2001 Sep; (121):27-31. PubMed ID: 11594241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actos (pioglitazone).
    TreatmentUpdate; 2001; 13(7):5-6. PubMed ID: 11794862
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetes medicine update. Old dogs, new tricks.
    Nakamoto M
    Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553
    [No Abstract]   [Full Text] [Related]  

  • 26. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 27. GSK fights compensation claims from UK patients who took rosiglitazone.
    Dyer C
    BMJ; 2013 Feb; 346():f695. PubMed ID: 23377792
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
    Lotz N
    MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
    [No Abstract]   [Full Text] [Related]  

  • 29. Serious liver injury. Leading reason for drug removals, restrictions.
    Meadows M
    FDA Consum; 2001; 35(3):8-9. PubMed ID: 11458559
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 31. Liver failure in a patient receiving rosiglitazone therapy.
    Su DH; Lai MY; Wu HP
    Diabet Med; 2006 Jan; 23(1):105-6. PubMed ID: 16409577
    [No Abstract]   [Full Text] [Related]  

  • 32. Thiazolidinediones for type 2 diabetes. All glitazones may exacerbate heart failure.
    Benbow A; Stewart M; Yeoman G
    BMJ; 2001 Jan; 322(7280):236. PubMed ID: 11159623
    [No Abstract]   [Full Text] [Related]  

  • 33. Is the tolerability of long-term thiazolidinedione therapy overstated?
    Malone RM; DeWalt DA; Pignone MP; Ives TJ
    J Am Coll Cardiol; 2003 Oct; 42(7):1334; author reply 1334-5. PubMed ID: 14522504
    [No Abstract]   [Full Text] [Related]  

  • 34. Rosiglitazone and liver failure.
    Isley WL; Oki JC
    Ann Intern Med; 2000 Sep; 133(5):393-4. PubMed ID: 10979889
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatotoxicity of thiazolidinediones.
    Isley WL; Oki JC
    Diabetes Obes Metab; 2001 Dec; 3(6):389-92. PubMed ID: 11903409
    [No Abstract]   [Full Text] [Related]  

  • 36. European regulatory body recommends suspension of rosiglitazone.
    Cohen D
    BMJ; 2010 Sep; 341():c5291. PubMed ID: 20870700
    [No Abstract]   [Full Text] [Related]  

  • 37. Playing the numbers game.
    Drug Ther Bull; 2011 Jan; 49(1):1. PubMed ID: 21220251
    [No Abstract]   [Full Text] [Related]  

  • 38. Rosiglitazone.
    Diabetes Obes Metab; 2000 Apr; 2(2):117. PubMed ID: 11220523
    [No Abstract]   [Full Text] [Related]  

  • 39. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
    Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
    [No Abstract]   [Full Text] [Related]  

  • 40. Rosiglitazone--useful drug but has side effects.
    Vidhya S; Mohan V
    J Assoc Physicians India; 2002 Apr; 50():615. PubMed ID: 12164432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.